CEO- Randall woods, was CEO of Novacardia which he sold in mid stage phase 3 trials to Merck for 350 million in 2007. In 2003 his company Corvas international was acquired by then Dendreon for 100 million which was highly growing at that time. Has 20 years experience at Eli Lilly & Company in sales and marketing. He's a guy that knows how to negotiate deals and build buyout target companies with great science.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.